All Drug LIST

S No. Date Drug List Price In USD     Action
1 Jun, 2020 Humira Drug Sales & Forecast
Humira (adalimumab) is a biologic therapy administered as a subcutaneous injection. It is approved to treat the following autoimmune diseases such as rheu...
USD $15.00
2 Apr, 2020 Trulicity Drug Sales & Forecast
Eli Lilly drug Trulicity, for the treatment of type 2 diabetes is approved in the United States and Europe in 2014 and Japan in 2015. MNG Tracker report t...
USD $20.00
3 Apr, 2020 Humalog Drug Sales & Forecast
Eli Lilly drug Humalog Mix75/25 and Humalog Mix50/50 are used to treat adults with diabetes for the control of high blood sugar. Its patent has expired in...
USD $20.00
4 Jun, 2020 AdroGel Drug Sales
AndroGel (testosterone gel) is a testosterone replacement therapy for males diagnosed with symptomatic low testosterone due to certain underlying conditio...
USD $15.00
5 Mar, 2020 Lynparza Drug Sales & Forecast
AstraZeneca drug Lynparza became the world’s ¬first approved PARP inhibitor in 2014. Initially indicated for the treatment of ovarian cancer, in 2017, ...
USD $20.00
6 Jun, 2020 Creon Drug Sales & Forecast
Creon (pancrelipase) is a pancreatic enzyme therapy for exocrine pancreatic insufficiency, a condition that occurs in patients with cystic fibrosis, chron...
USD $15.00
7 Jun, 2020 Viekira Pak Drug Sales
Viekira Pak is an all-oral, short-course, interferon-free therapy, with or without ribavirin, for the treatment of adult patients with genotype 1 chronic ...
USD $15.00
8 Mar, 2020 Imfinzi Drug Sales & Forecast
AstraZeneca drug Imfinzi is approved for lung and bladder cancer in 2017. Imfinzi, a human mAb that binds to PD-L1 and blocks the interaction of PD-L1 wit...
USD $20.00
9 Mar, 2020 Brilinta/Brilique Drug Sales & Forecast
Brilinta/Brilique (ticagrelor) is an oral antiplatelet for acute coronary syndromes (ACS). Brilinta/Brilique, one of AstraZeneca Growth Platforms, is an o...
USD $20.00
10 Mar, 2020 Crestor Drug Sales & Forecast
AstraZeneca drug Crestor is approved in more than 115 countries for the treatment of dyslipidaemia and hypercholesterolaemia. MNG Tracker report title “...
USD $20.00
11 Mar, 2020 Tagrisso Drug Sales & Forecast
AstraZeneca drug Tagrisso is approved for lung cancer in 2015. Tagrisso is a best-in-class, highly selective, irreversible inhibitor of the activating sen...
USD $20.00
12 Apr, 2020 Alimta Drug Sales & Forecast
Eli Lilly drug Alimta is used for the treatment of lung cancer. Its vitamin regimen patent plus pediatric exclusivity will expire in May 2022 in United St...
USD $20.00
13 Apr, 2020 Forteo Drug Sales & Forecast
Eli Lilly drug Forteo, for the treatment of osteoporosis in postmenopausal women and men at high risk for fracture and for glucocorticoid-induced osteopor...
USD $20.00
14 Apr, 2020 Basaglar Drug Sales & Forecast
Eli Lilly drug Basaglar (insulin glargine injection), a long-acting human insulin analog for the treatment of diabetes launched in the United Sates in 201...
USD $20.00
15 Apr, 2020 Atripla Drug Sales & Forecast
GileadSciences drug Atripla is an oral formulation indicated as a complete regimen for the treatment of HIV-1 infection in certain patients. Atripla is a ...
USD $15.00
16 Apr, 2020 Biktarvy Drug Sales & Forecast
GileadSciences drug Biktarvy is an oral formulation dosed once a day for the treatment of HIV-1 infection in certain patients. Biktarvy is a single tablet...
USD $15.00
17 Apr, 2020 Odefsey Drug Sales & Forecast
GileadSciences drug Odefsey is an oral formulation dosed once a day for the treatment of HIV-1 infection in certain patients. Odefsey is a single tablet r...
USD $15.00
18 Apr, 2020 Vemlidy Drug Sales & Forecast
GileadSciences drug Vemlidy is an oral formulation of TAF dosed once a day for the treatment of chronic hepatitis B virus (HBV) infection in adults with c...
USD $15.00
19 Apr, 2020 Vosevi Drug Sales & Forecast
GileadSciences drug Vosevi is an oral formulation of a once-daily, single tablet regimen of sofosbuvir, velpatasvir and voxilaprevir for the re-treatment ...
USD $15.00
20 Apr, 2020 Yescarta Drug Sales & Forecast
GileadSciences drug Yescarta (axicabtagene ciloleucel) is a (chimeric antigen receptor cell therapy) CAR-T for the treatment of adult patients with relaps...
USD $15.00
21 Apr, 2020 Benlysta Drug Sales & Forecast
GSK drug Benlysta is the world’s first and only biologic medicine specifically approved for adult and paediatric lupus to treat systemic lupus erythemat...
USD $15.00
22 Apr, 2020 Bexsero Vaccine Sales & Forecast
Since its launch in 2015, GSK Bexsero has become the industry-leading meningitis B vaccine. In the United States, where it is licensed for 10 to 25 year o...
USD $15.00
23 Apr, 2020 Juluca Drug Sales & Forecast
GSK received United States FDA approval for Juluca in 2017, a once-daily, single pill 2DR regimen for HIV. Juluca combines dolutegravir with rilpivirine (...
USD $15.00
24 Apr, 2020 Shingrix Vaccine Sales & Forecast
Shingrix marks a step change in the prevention of shingles, a painful and potentially serious illness. The vaccine addresses the age-related decline in im...
USD $15.00
25 Apr, 2020 Zejula Drug Sales & Forecast
Zejula, GlaxoSmithKline (GSK) oral PARP inhibitor, is approved in the United States and Europe for women with recurrent ovarian cancer. MNG Tracker report...
USD $15.00
26 Apr, 2020 Darzalex Drug Sales & Forecast
Johnson & Johnson drug Darzalex (daratumumab) is a prescription medicine used to treat a type of blood cancer called multiple myeloma. Darzalex is not che...
USD $15.00
27 Apr, 2020 Erleada Drug Sales & Forecast
Johnson & Johnson drug Erleada (apalutamide) is an androgen receptor (AR) inhibitor indicated for the treatment of patients with non-metastatic castration...
USD $15.00
28 Apr, 2020 Imbruvica Drug Sales & Forecast
Johnson & Johnson drug Imbruvica (ibrutinib) is an oral, once-daily medicine that works differently than chemotherapy as it blocks a protein called Bruton...
USD $15.00
29 Apr, 2020 Stelara Drug Sales & Forecast
Johnson & Johnson drug Stelara (ustekinumab), a treatment for adults and children with moderate to severe plaque psoriasis, for adults with active psoriat...
USD $15.00
30 Apr, 2020 Bridion Drug Sales & Forecast
Merck Bridion (sugammadex) Injection, a medication for the reversal of two types of neuromuscular blocking agents used during surgery. MNG Tracker report ...
USD $15.00
31 Apr, 2020 Gardasil/Gardasil 9 Vaccine Sales & Forecast
Merck Gardasil (Human Papillomavirus Quadrivalent [Types 6, 11, 16 and 18] Vaccine, Recombinant) and Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Re...
USD $15.00
32 Apr, 2020 Keytruda Drug Sales & Forecast
Merck drug Keytruda is used for the treatment of multiple types of cancer such as non-small-cell lung cancer (NSCLC), small-cell lung cancer (SCLC), head ...
USD $15.00
33 Apr, 2020 ProQuad Vaccine Sales & Forecast
Merck ProQuad is a pediatric combination vaccine to protect against measles, mumps, rubella and varicella in children 12 months through 12 years of age. U...
USD $15.00
34 Apr, 2020 RotaTeq Vaccine Sales & Forecast
RotaTeq is a vaccine indicated for the prevention of rotavirus gastroenteritis (diarrhoea and vomiting) caused by rotavirus infections types G1, G2, G3, G...
USD $15.00
35 Apr, 2020 Varivax Vaccine Sales & Forecast
Merck Varivax is a vaccine indicated for active immunization for the prevention of varicella in individuals 12 months of age and older. The Food and Drug ...
USD $15.00
36 Apr, 2020 Chantix/Champix Drug Sales & Forecast
Chantix (also known as Champix in the EU and other countries) was approved by the FDA in May 2006 as a prescription medication that, along with support, h...
USD $15.00
37 Apr, 2020 Ibrance Drug Sales & Forecast
Pfizer drug Ibrance is used for the treatment of adult patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (H...
USD $15.00
38 Apr, 2020 Prevnar 13/Prevenar 13 Vaccine Sales & Forecast
Prevnar 13/Prevenar 13 is Pfizer vaccines for prevention of pneumococcal disease. In 2014, the Advisory Committee on Immunization Practices (ACIP) voted t...
USD $15.00
39 May, 2020 Xeljanz Drug Sales & Forecast
Pfizer drug Xeljanz (tofacitinib) is approved in the United States for adult patients in three indications: moderately to severely active rheumatoid arthr...
USD $15.00
40 May, 2020 Pfizer's Xtandi Drug Sales & Forecast
Pfizer drug Xtandi is FDA-approved for the treatment of non-metastatic and metastatic castration-resistant prostate cancer as well as metastatic castratio...
USD $15.00
41 May, 2020 Alecensa Drug Sales & Forecast
Roche drug Alecensa is a highly selective, CNS active, oral medicine created at Chugai Kamakura Research Laboratories and is being developed for people wi...
USD $15.00
42 May, 2020 Avastin Drug Sales & Forecast
Roche drug Avastin is a prescription-only medicine that is a solution for intravenous infusion. It is a biologic antibody designed to specifically bind to...
USD $15.00
43 May, 2020 Hemlibra Drug Sales & Forecast
Roche drug Hemlibra is a prophylactic (preventative) treatment that can be administered by an injection of a ready-to-use solution under the skin (subcuta...
USD $15.00
44 May, 2020 Herceptin Drug Sales & Forecast
Roche drug Herceptin (trastuzumab) is a humanized monoclonal antibody, designed to target and block the function of HER2, a protein produced by a specific...
USD $15.00
45 May, 2020 Kadcyla Drug Sales & Forecast
Roche drug Kadcyla is an antibody-drug conjugate (ADC) engineered to deliver potent chemotherapy directly to HER2-positive cancer cells, potentially limit...
USD $15.00
46 May, 2020 Ocrevus Drug Sales & Forecast
Roche drug Ocrevus (ocrelizumab) is the first and only therapy approved for both relapsing forms of multiple sclerosis (RMS) (including clinically isolate...
USD $15.00
47 May, 2020 Perjeta Drug Sales & Forecast
Roche drug Perjeta is given intravenously and targets the HER2 protein. It was approved in 2012 for the treatment of patients with advanced or late-stage ...
USD $15.00
48 May, 2020 Tecentriq Drug Sales & Forecast
Roche drug Tecentriq is a cancer immunotherapy that has the potential to be used as a foundational combination partner with other immunotherapies, targete...
USD $15.00
49 May, 2020 Aubagio Drug Sales & Forecast
Sanofi drug Aubagio (teriflunomide), a small molecule immunomodulatory agent with anti-inflammatory properties, is a once-daily oral therapy. In 2017, San...
USD $15.00
50 May, 2020 Cerezyme Drug Sales & Forecast
Sanofi drug Cerezyme (imiglucerase) is an enzyme replacement therapy used to treat Gaucher disease, an inherited and potentially life-threatening LSD. It ...
USD $15.00
51 May, 2020 Fabrazyme Drug Sales & Forecast
Sanofi drug Fabrazyme (agalsidase beta) is an enzyme replacement therapy used to treat Fabry disease, an inherited and potentially life threatening LSD. F...
USD $15.00
52 May, 2020 Dupixent Drug Sales & Forecast
Sanofi drug Dupixent (dupilumab), a human monoclonal antibody, binds to the interleukin-4 receptor (IL-4R) and has been shown to specifically inhibit over...
USD $15.00
53 May, 2020 Jevtana Drug Sales & Forecast
Sanofi drug Jevtana (cabazitaxel), a chemotherapy drug and cytotoxic agent, is a semi-synthetic second-generation taxane which prevents many cancer cells ...
USD $15.00
54 May, 2020 Lantus Drug Sales & Forecast
Sanofi drug Lantus is a long-acting analog of human insulin, indicated for once-daily administration for the treatment of diabetes mellitus in adults, ado...
USD $15.00
55 Jun, 2020 Lovenox/Clexane Drug Sales & Forecast
Sanofi drug Lovenox/Clexane (enoxaparin sodium) is a low molecular weight heparin (LMWH) for use in the prophylaxis and treatment of venous thromboembolis...
USD $15.00
56 Jun, 2020 Myozyme/Lumizyme Drug Sales & Forecast
Sanofi drug Myozyme/Lumizyme (alglucosidase alfa, intravenous infusion) are recombinant forms of the same human enzyme and are enzyme replacement therapie...
USD $15.00
57 Jun, 2020 Toujeo Drug Sales & Forecast
Toujeo is a solution for injection that contains the active substance insulin glargine. It is long-acting human insulin analogue indicated to improve glyc...
USD $15.00
58 Jun, 2020 Baraclude Drug Sales & Forecast
BMS drug Baraclude was first approved in March 2005 and subsequent approvals in Japan and the five major EU markets (France, Germany, Italy, Spain, and th...
USD $15.00
59 Jun, 2020 Eliquis Drug Sales & Forecast
BMS drug Eliquis (apixaban) is an oral Factor Xa inhibitor, targeted at stroke prevention in adult patients with NVAF and the prevention and treatment of ...
USD $15.00
60 Jun, 2020 Empliciti Drug Sales & Forecast
BMS and AbbVie jointly develop and commercialize Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma. Both parties participat...
USD $15.00
61 Jun, 2020 Opdivo/Yervoy Drug Sales & Forecast
Opdivo is a programmed death-1 (PD-1) immune checkpoint inhibitor that is designed to uniquely harness the body’s own immune system to help restore anti...
USD $15.00
62 Jun, 2020 Orencia Drug Sales & Forecast
BMS drug Orencia (abatacept), a biological product, is a fusion protein indicated for adult patients with moderately to severely active rheumatoid arthrit...
USD $15.00
63 Jun, 2020 Sprycel Drug Sales & Forecast
BMS drug Sprycel (dasatinib) is an oral inhibitor of multiple tyrosine kinase indicated for the first-line treatment of patients with Philadelphia chromos...
USD $15.00